Reducing glucose infusion safely prevents hyperglycemia in post-surgical children

Clinical Nutrition

Volumn 30, Issue 6, 2011, Pages 786-792

  Verbruggen, Sascha C A T ^a   de Betue, Carlijn T I ^a   Schierbeek, Henk ^a   Chacko, Shaji ^b   van Adrichem, Leon N A ^a   Verhoeven, Jennifer ^a   van Goudoever, Johannes B ^a,c,d   Joosten, Koen F M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b CHILDREN S NUTRITION RESEARCH CENTER   (United States)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amino acid; Catabolism; Critical care; Gluconeogenesis; Glycogenolysis; Tight glucose

Indexed keywords

AMINO ACID; CARBON 13; DEUTERIUM OXIDE; GLUCOSE; LEUCINE; PHENYLALANINE; TYROSINE;

AMINO ACID METABOLISM; ARTICLE; CHILD CARE; CHILD NUTRITION; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; CROSSOVER PROCEDURE; DOSE RESPONSE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; GLYCEMIC CONTROL; GLYCOGENOLYSIS; HUMAN; HYPERGLYCEMIA; INFANT; INTENSIVE CARE; ISOTOPE LABELING; LOW DRUG DOSE; MALE; POSTOPERATIVE CARE; PROTEIN CONTENT; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL;

AMINO ACIDS; BLOOD GLUCOSE; CRANIOSYNOSTOSES; CROSS-OVER STUDIES; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFANT; INFUSIONS, INTRAVENOUS; MALE; STATISTICS, NONPARAMETRIC;

EID: 82255186401     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.05.011     Document Type: Article

References (55)

1. Zijlmans W.C., van Kempen A.A., Serlie M.J., Sauerwein H.P. Glucose metabolism in children: influence of age, fasting, and infectious diseases. Metabolism 2009, 58(9):1356-1365.
2. Verbruggen S.C., Joosten K.F., Castillo L., van Goudoever J.B. Insulin therapy in the pediatric intensive care unit. Clin Nutr 2007, 26(6):677-690.
3. Wilson M., Weinreb J., Hoo G.W. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007, 30(4):1005-1011.
4. Wiener R.S., Wiener D.C., Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300(8):933-944.
5. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009, 373(9663):547-556.
6. Bober E., Buyukgebiz A. Hypoglycemia and its effects on the brain in children with type 1 diabetes mellitus. Pediatr Endocrinol Rev 2005, 2(3):378-382.
7. Vannucci R.C., Vannucci S.J. Glucose metabolism in the developing brain. Semin Perinatol 2000, 24(2):107-115.
8. Flykanaka-Gantenbein C. Hypoglycemia in childhood: long-term effects. Pediatr Endocrinol Rev 2004, 1(Suppl. 3):530-536.
9. Solomon T., Felix J.M., Samuel M., et al. Hypoglycaemia in paediatric admissions in Mozambique. Lancet 1994, 343(8890):149-150.
10. Chaussain J.L., Georges P., Calzada L., Job J.C. Glycemic response to 24-hour fast in normal children: III. Influence of age. J Pediatr 1977, 91(5):711-714.
11. Joosten K., Verbruggen S.C., Verhoeven J.J. Glycaemic control in paediatric critical care. Lancet 2009, 373(9673):1423-1424. author reply 4.
12. Preissig C., Rigby M. Glycaemic control in paediatric critical care. Lancet 2009, 373(9673):1423. author reply 4.
13. Leteurtre S., Martinot A., Duhamel A., et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003, 362(9379):192-197.
14. Shann F., Pearson G., Slater A., Wilkinson K. Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 1997, 23(2):201-207.
15. Slater A., Shann F., Pearson G. PIM2: a revised version of the paediatric index of mortality. Intensive Care Med 2003, 29(2):278-285.
16. Pollack M.M., Patel K.M., Ruttimann U.E. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996, 24(5):743-752.
17. Kalhan S.C., Kilic I. Carbohydrate as nutrient in the infant and child: range of acceptable intake. Eur J Clin Nutr 1999, 53(Suppl. 1):S94-S100.
18. Argoud G.M., Schade D.S., Eaton R.P. Underestimation of hepatic glucose production by radioactive and stable tracers. Am J Phys 1987, 252(5 Pt 1):E606-E615.
19. Chacko S.K., Sunehag A.L., Sharma S., Sauer P.J., Haymond M.W. Measurement of gluconeogenesis using glucose fragments and mass spectrometry after ingestion of deuterium oxide. J Appl Phys 2008, 104(4):944-951.
20. Matthews D.E., Schwarz H.P., Yang R.D., Motil K.J., Young V.R., Bier D.M. Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 1982, 31(11):1105-1112.
21. Husek P. Amino acid derivatization and analysis in five minutes. FEBS Lett 1991, 280(2):354-356.
22. el-Khoury A.E., Sanchez M., Fukagawa N.K., Young V.R. Whole body protein synthesis in healthy adult humans: 13CO2 technique vs. plasma precursor approach. Am J Phys 1995, 268(1 Pt 1):E174-E184.
23. Spear M.L., Darmaun D., Sager B.K., Parsons W.R., Haymond M.W. Use of [13C]bicarbonate infusion for measurement of CO2 production. Am J Phys 1995, 268(6 Pt 1):E1123-E1127.
24. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345(19):1359-1367.
25. Altszuler N., De Bodo R.C., Steele R., Wall J.S. Carbohydrate metabolism of hypophysectomized dogs as studied with radioactive glucose. Am J Phys 1956, 187(1):25-31.
26. Steele R., Wall J.S., De Bodo R.C., Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Phys 1956, 187(1):15-24.
27. Matthews D.E., Motil K.J., Rohrbaugh D.K., Burke J.F., Young V.R., Bier D.M. Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C]leucine. Am J Phys 1980, 238(5):E473-E479.
28. Clarke J.T., Bier D.M. The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state. Metabolism 1982, 31(10):999-1005.
29. Thompson G.N., Pacy P.J., Merritt H., et al. Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model. Am J Phys 1989, 256(5 Pt 1):E631-E639.
30. Sy J., Gourishankar A., Gordon W.E., et al. Bicarbonate kinetics and predicted energy expenditure in critically ill children. Am J Clin Nutr 2008, 88(2):340-347.
31. Marchini J.S., Castillo L., Chapman T.E., Vogt J.A., Ajami A., Young V.R. Phenylalanine conversion to tyrosine: comparative determination with L-[ring-2H5]phenylalanine and L-[1-13C]phenylalanine as tracers in man. Metabolism 1993, 42(10):1316-1322.
32. Marchini J.S., Cortiella J., Hiramatsu T., Castillo L., Chapman T.E., Young V.R. Phenylalanine and tyrosine kinetics for different patterns and indispensable amino acid intakes in adult humans. Am J Clin Nutr 1994, 60(1):79-86.
33. Argaman Z., Young V.R., Noviski N., et al. Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med 2003, 31(2):591-597.
34. Castillo L., Yu Y.M., Marchini J.S., et al. Phenylalanine and tyrosine kinetics in critically ill children with sepsis. Pediatr Res 1994, 35(5):580-588.
35. Golden M.H., Waterlow J.C. Total protein synthesis in elderly people: a comparison of results with [15N]glycine and [14C]leucine. Clin Sci Mol Med 1977, 53(3):277-288.
36. Bier D.M., Leake R.D., Haymond M.W., et al. Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977, 26(11):1016-1023.
37. Grasso S., Fallucca F., Mazzone D., Giangrande L., Romeo M.G., Reitano G. Inhibition of glucagon secretion in the human newborn by glucose infusion. Diabetes 1983, 32(6):489-492.
38. Boden G., Chen X., Stein T.P. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2001, 280(1):E23-E30.
39. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 2004, 114(9):1187-1195.
40. Cortiella J., Marchini J.S., Branch S., Chapman T.E., Young V.R. Phenylalanine and tyrosine kinetics in relation to altered protein and phenylalanine and tyrosine intakes in healthy young men. Am J Clin Nutr 1992, 56(3):517-525.
41. Young V.R., Marchini J.S. Mechanisms and nutritional significance of metabolic responses to altered intakes of protein and amino acids, with reference to nutritional adaptation in humans. Am J Clin Nutr 1990, 51(2):270-289.
42. Tessari P., Kiwanuka E., Zanetti M., Barazzoni R. Postprandial body protein synthesis and amino acid catabolism measured with leucine and phenylalanine-tyrosine tracers. Am J Physiol Endocrinol Metab 2003, 284(5):E1037-E1042.
43. Garrett R.H.C.M.G. Principles of biochemistry with a human focus 2002, Brooks/Cole, USA.
44. Biolo G., De Cicco M., Lorenzon S., et al. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med 2008, 36(6):1768-1775.
45. Verbruggen S., Sy J., Gordon W.E., et al. Ontogeny of methionine utilization and splanchnic uptake in critically ill children. Am J Physiol Endocrinol Metab 2009, 297:E1046-E1055.
46. Hertz D.E., Karn C.A., Liu Y.M., Liechty E.A., Denne S.C. Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns. J Clin Invest 1993, 92(4):1752-1758.
47. Jahoor F., Shangraw R.E., Miyoshi H., Wallfish H., Herndon D.N., Wolfe R.R. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am J Phys 1989, 257(3 Pt 1):E323-E331.
48. Lecker S.H., Solomon V., Mitch W.E., Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999, 129(Suppl. 1S):227S-237S.
49. Voisin L., Breuille D., Combaret L., et al. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 1996, 97(7):1610-1617.
50. Deval C., Mordier S., Obled C., et al. Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J 2001, 360(Pt 1):143-150.
51. Smith I.J., Lecker S.H., Hasselgren P.O. Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 2008, 295(4):E762-E771.
52. Wang X., Hu Z., Hu J., Du J., Mitch W.E. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006, 147(9):4160-4168.
53. Crossland H., Constantin-Teodosiu D., Gardiner S.M., Constantin D., Greenhaff P.L. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 2008, 586(Pt 22):5589-5600.
54. Crossland H., Constantin-Teodosiu D., Greenhaff P.L., Gardiner S.M. Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. J Physiol 2010, 588(Pt 8):1333-1347.
55. Burns S.P., Cohen R.D., Krebs M., Brehm A., Krssak M., et al. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 2003, 46:917-925. Diabetologia 2004;47(1):141; author reply 2-3.